Gabapentin Capsules — Class III drug recall D-0311-2025
Ongoing recall by SUN PHARMACEUTICAL INDUSTRIES INC, reported 2025-04-16, distributed nationwide. Cross Contamination
| Recall number | D-0311-2025 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ, United States |
| Recall initiated | 2025-03-04 |
| Classified | 2025-04-04 |
| Reported by FDA | 2025-04-16 |
| Distributed | Nationwide (US) |
| Quantity | 12,876 bottles |
| NDC | 62756-0137, 62756-0137-01, 62756-0137-02, 62756-0137-03, 62756-0137-04, 62756-0137-05, 62756-0138, 62756-0138-01, 62756-0138-02, 62756-0138-03, 62756-0138-04, 62756-0138-05, 62756-0139, 62756-0139-01, 62756-0139-02, 62756-0139-03, 62756-0139-04, 62756-0139-05, 62756-0202, 62756-0202-01, 62756-0202-03, 62756-0204, 62756-0204-01, 62756-0204-03 |
| Expiration dates | 2025-04, 2025-07, 2025-08 |
Product
Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Reason for recall
Cross Contamination
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0311-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.